3 healthcare shares to buy and hold for the next decade

If you’re interested in buy and hold investing then I think the healthcare sector is one of the best places to look for ideas right now.

This is due to the long-term growth potential of the sector from increased chronic disease burden and ageing and growing populations.

Three top healthcare shares that I believe could be worth considering with a long-term view are as follows:

Cochlear Limited (ASX: COH)

Cochlear is one of the world’s leading hearing solutions companies and a great buy and hold investment option in my opinion. In a recent presentation management estimated that there are 15 million people globally that could benefit from a cochlear or bone conduction implant. This means that implantable hearing solutions have penetrated less than 5% of the total addressable market, giving Cochlear a significant runway for growth.

Nanosonics Ltd (ASX: NAN)

Nanosonics is the infection control specialist behind the popular trophon EPR product. This product has been growing its installed base at a strong rate over the last few years due to being wholly effective and regarded as the best in its class. At the end of FY 2018 the total global installed base had grown 25% to 17,740 units. This means that Nanosonics has just 15% of the overall market opportunity estimated to be 120,000 units globally. I think it is well positioned to continue growing its installed base over the next decade.

Volpara Health Technologies Ltd (ASX: VHT)

At the small end of the market I think Volpara Health Technologies is a great long-term option for investors. The healthcare technology company provides an increasingly popular breast imaging analytics and analysis software. It has been growing its share of the U.S. breast screening market at an impressive rate over the last 12 months, leading to a significant jump in annual recurring revenues. I expect more of the same in FY 2019 and beyond due to the quality of its offering and recent product enhancements.

In addition to those healthcare shares, I think these fintech stars could be great long-term options.

3 exciting fintech shares to buy and hold

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Atlassian.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited and VOLPARA FPO NZ. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!